Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page
- Check4 days agoChange DetectedRemoved sponsor/affiliation blocks for Moffitt Cancer Center and the associated 'Helpful Links' section.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous v3.4.1.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1, likely a template/UI adjustment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedThe update timestamp label on the Study Details page changed from 'Last Update Posted (Estimated)' to 'Last Update Posted', a minor presentation change to study metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 on the page, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations for Florida, Georgia, and Ohio were added, clarifying where the study is conducted. The revision is updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.4%

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.